Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

RISE Registry Helps ACR Members Successfully Navigate MIPS

David I. Daikh, MD, PhD  |  Issue: April 2018  |  April 26, 2018

These performance categories should seem very familiar to most providers; three of these categories are legacy CMS programs: PQRS, the EHR Incentive Program (Meaningful Use) and the Value-Based Modifier (VBM). The fourth category, improvement activities, is a new catch-all for other previous CMS improvement initiatives.

Early Adopters of RISE Benefit Big

As of March 15, 2018, preliminary reports show an 86% increase in rheumatologists who used RISE for quality reporting compared with the final year of reporting for the PQRS program in 2016.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Out of the providers/practices that used RISE for reporting all MIPS categories for the 2017 performance year, almost 17% submitted 100 points (maximum score) to the QPP, and 47% of practices/providers met or exceeded the 70-point exceptional threshold. Out of the maximum 60 points attainable for the quality measures category, the average score for this category sub­mitted to CMS was 49.41.

The average MIPS Composite Score submitted to CMS for users that submitted all MIPS categories with RISE was 88.72 out of a possible 100 points This not only means that practices are obtaining the maximum benefit of this incentive program, but it underscores that rheumatologists are routinely providing high-quality care as defined by the QPP.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

MIPS Performance Year 2 (2018)

The CMS estimates that 3,340 rheuma­tologists are MIPS eligible in 2018. This number is down from the 2017 number because the CMS increased the low-volume threshold for reporting in 2018. For the current year, if rheumatologists have less than or equal to $90,000 in Part B allowed charges or 200 or fewer Part B beneficiaries, then these providers are exempt for reporting into the QPP.2

Another substantial difference for the 2018 performance year is that the maximum payment adjustment for penalties and bonuses increases from 4% to 5%. Other key differences between the 2017 and 2018 performance year of the program are the data requirements for reporting.

The performance threshold increases from three points to 15 points in 2018. This means that providers must submit a MIPS composite score of at least 15 points to qualify for a neutral payment adjustment. CMS did maintain the exceptional performance threshold at 70 points, which is good news for RISE users who were already able to achieve a composite score of 70 or above in the first year. Further, providers had to report on 50% of their patients regardless of payer for any continuous 90 days in 2017, but rheumatologists will now have to report 60% of their patients for the entire calendar year for the Quality category.

Page: 1 2 3 | Single Page
Share: 

Filed under:President's Perspective Tagged with:ACR Rise RegistryAmerican College of Rheumatology (ACR)MACRAMIPS

Related Articles

    2023 Medicare Physician Fee Schedule Final Rule for Quality Payment Program Published

    January 6, 2023

    The ACR highlights essential policy and reporting changes to the Quality Payment Program for performance year 2023 and beyond. Key changes include policies regarding the development of new MIPS Value Pathways and refinement of subgroup participation.

    2024 Proposed Rule for the Quality Payment Program Released

    August 17, 2023

    See key changes for the Merit-Based Incentive Payment System for the 2024 performance year as outlined in the proposed rule.

    2022 PFS Final Rule for the Quality Payment Program Published

    December 2, 2021

    The ACR highlights essential information for providers for 2022 MIPS reporting in the 2022 Medicare Physician Fee Schedule Final Rule, published Nov. 2.

    Providers Using RISE Have Advantage with 2017 MIPS Reporting

    March 15, 2018

    Hundreds of rheumatology providers across the country are finalizing submissions for the first year of reporting under the Merit-Based Incentive Payment System (MIPS). According to a presentation at the 2017 ACR/ARHP Annual Meeting in San Diego, providers that participate in and submit through the Rheumatology Informatics System for Effectiveness (RISE) Registry are poised to perform…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences